inclusion

Advances in medicine across the board are only made possible through clinical trials. Right now, however, researchers struggle to engage minorities in this life-saving process. Some clinical investigators imagine difficulties before they even begin. Some have all but given up, mistakenly believing that these populations have low participation numbers because they're 'difficult' or unwilling. We know better. We also know that study investigators, study site staff, and big pharma are not necessarily well-suited to address the complex communications demands of patient recruitment— particularly that of special populations.

Clinical Ambassador translates research into cultural relevance.

Our goals are access and equity, and our services build interest and enthusiasm based on clear and realistic expectations. We provide the broadest range of stakeholders— often those who have been underrepresented in clinical research— with information they can use, building real empowerment and resulting in more informed decisions.

Access to the very best medical interventions (drugs, devices, and other therapies) isn't supposed to be limited. Everyone deserves equal access to medicine that works, and this depends on equal access to clinical trials. It's as simple as that.

Despite a federal mandate for inclusion, minorities and other special populations are not being recruited to participate in clinical trials in a way that reflects today's reality, or the "Browning of America." Clinical Ambassador brings access and empowerment to the arena, and promotes equity in health and healthcare through broader understanding of minority inclusion for all stakeholders.

The lack of access to high-quality medical care for minorities— along with a combination of other social factors such as education, income and lifestyle— have led to higher incidence, and often times, higher mortality (death) rates for many diseases including HIV/AIDS, asthma, cardiovascular diseases, diabetes, Alzheimer's, and cancer.

At Clinical Ambassador, we focus on improving communication between participants and researchers. This takes the form of market research, community outreach, study-based marketing, patient recruitment, pre-screening, and plain language informed consent. Across the board, we make the process simple, clear and fun— shifting the paradigm and making sure that new drugs and life changing treatments can reach the people who need them most.

We've partnered with Antidote.me to deliver a podcast series exploring these issues. Check it out below: